- Home
- LNTH vs NOVT Comparison
LNTH vs NOVT Comparison
Compare LNTH & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | NOVT |
|---|---|---|
| Founded | 1956 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.9B |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | LNTH | NOVT |
|---|---|---|
| Price | $76.10 | $117.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $83.20 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 958.1K | 360.5K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.41 | 1.47 |
| Revenue | $343,374,000.00 | ★ $521,290,000.00 |
| Revenue This Year | N/A | $8.71 |
| Revenue Next Year | $13.93 | $6.47 |
| P/E Ratio | ★ $22.31 | $79.30 |
| Revenue Growth | 3.62 | ★ 35.49 |
| 52 Week Low | $47.27 | $98.27 |
| 52 Week High | $108.86 | $149.95 |
Technical Indicators
Market Signals| Indicator | LNTH | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 42.08 |
| Support Level | $72.33 | $111.58 |
| Resistance Level | $84.77 | $124.97 |
| Average True Range (ATR) | 2.47 | 5.19 |
| MACD | -0.58 | 0.42 |
| Stochastic Oscillator | 40.96 | 44.24 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About NOVT Novanta Inc.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.